Back
Aviat Networks Vs. Kymera Therapeutics Industry Stock Comparison
Sell
25
AVNW
Aviat Networks
Last Price:
14.42
Seasonality Move:
19.34%
Buy
76
KYMR
Kymera Therapeutics
Last Price:
50.95
Seasonality Move:
52.76%
Sell
25
Aviat Networks (AVNW)
is a Sell
Is Aviat Networks a Buy, Sell or Hold?
- The current Aviat Networks [AVNW] share price is $14.39. The Score for AVNW is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AVNW is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $50.94. The Score for KYMR is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AVNW Stock Price Chart
What is Aviat Networks's stock price today?
-
The Aviat Networks share price today is $14.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVNW is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $50.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVNW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.81 | Sell |
| Relative Strength Index (14 RSI): | 23.7 | Sell |
| Chaikin Money Flow: | 161620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.97 - 23.37) | Sell |
| Bollinger Bands (100): | (21.29 - 28.97) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 63.02 | Buy |
| Chaikin Money Flow: | 210505 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.39 - 49.17) | Buy |
| Bollinger Bands (100): | (38 - 49.56) | Buy |
AVNW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.04 | Sell |
| 20-day SMA: | 20.4 | Sell |
| 50-day SMA: | 21.92 | Sell |
| 200-day SMA: | 29.13 | Sell |
| 8-day EMA: | 17.19 | Sell |
| 20-day EMA: | 19.41 | Sell |
| 50-day EMA: | 21.82 | Sell |
| 200-day EMA: | 27.09 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.18 | Buy |
| 20-day SMA: | 47.73 | Buy |
| 50-day SMA: | 47.1 | Buy |
| 200-day SMA: | 40.25 | Buy |
| 8-day EMA: | 48.87 | Buy |
| 20-day EMA: | 47.89 | Buy |
| 50-day EMA: | 46.63 | Buy |
| 200-day EMA: | 39.92 | Buy |
Aviat Networks Earnings Growth & AVNW Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $1.98 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.
Aviat Networks Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||